Fractalkine (CX3CL1) levels in patients with Behcet's disease and Neuro-Behcet's disease


Ceyla I., Tuba T. K., Esra A., Banu O., Isil F., Ali G. M., ...More

JOURNAL OF THE NEUROLOGICAL SCIENCES, vol.315, pp.120-122, 2012 (SCI-Expanded, Scopus)

Abstract

Objective: The aim of the present study was to assess the role of CX3CL1 in patients with active and inactive Behcet's Disease (BD), Neuro-Behcet's Disease (NBD) and control subjects.